CORC

浏览/检索结果: 共51条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Behaviors of Glioblastoma Cells in in Vitro Microenvironments. 期刊论文
Scientific reports, 2019, 卷号: No.1, 页码: 85
作者:  Wenwen Diao;  Xuezhi Tong;  Cheng Yang;  Fengrong Zhang;  Chun Bao
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/13
Behaviors of Glioblastoma Cells in in Vitro Microenvironments 期刊论文
Scientific Reports, 2019, 卷号: Vol.9
作者:  Wenwen Diao;  Xuezhi Tong;  Cheng Yang;  Fengrong Zhang;  Chun Bao
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/13
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载:21/0  |  提交时间:2020/01/03
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study 期刊论文
2019, 卷号: 31, 期号: 3, 页码: 481-+
作者:  Xing, Puyuan;  Ma, Di;  Wang, Qiang;  Hao, Xuezhi;  Wang, Mengzhao
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma 期刊论文
2019, 卷号: 9, 页码: 556
作者:  Han, Xiaohong;  Tan, Qiaoyun;  Yang, Sheng;  Li, Junling;  Xu, Jianping
收藏  |  浏览/下载:19/0  |  提交时间:2020/01/03
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment 期刊论文
2019, 卷号: 31, 期号: 2, 页码: 349-356
作者:  Xu, Haiyan;  Ma, Di;  Yang, Guangjian;  Li, Junling;  Hao, Xuezhi
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
Expression of CENPE and its prognostic role in non-small cell lung cancer 期刊论文
2019, 卷号: 14, 期号: 1, 页码: 497-502
作者:  Hao, Xuezhi;  Qu, Tao
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib 期刊论文
2019, 卷号: 14, 期号: 3, 页码: 335-342
作者:  Mu, Yuxin;  Hao, Xuezhi;  Yang, Ke;  Ma, Di;  Wang, Shouzheng
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Clinicopathologic characteristics and outcome of patients with different EGFR mutations 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:  Zhou, Shengyu;  Hu, Xingsheng;  Wang, Yan;  Li, Junling;  Zhou, Liqiang
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace